Dapawalk GM (10/2/500)

Description

 Dapawalk GM (10/2/500) is a combination anti-diabetic medicine from Biophar Lifesciences, designed for the effective management of Type 2 Diabetes Mellitus. It combines Dapagliflozin, Glimepiride, and Metformin ER, providing powerful control over blood glucose levels by improving insulin action, reducing sugar production, and supporting glucose elimination through urine.

🔬 Mechanism of Action:

• Dapagliflozin: Helps the body remove excess glucose through urine by inhibiting SGLT2.

• Glimepiride: Enhances insulin secretion naturally.

• Metformin ER: Controls hepatic glucose production & increases insulin sensitivity with a sustained release effect.

✨ Benefits
✔ Triple therapy for advanced diabetes
✔ Reduces fasting & post-meal sugar levels
✔ Extended release formula for better control
✔ Low risk of gastric irritation
✔ Helps reduce cardiovascular risk factors

⚠️ Prescription Required: To be consumed only under medical supervision.

📍 Manufacturer

Biophar Lifesciences Pvt. Ltd.
WHO–GMP Certified Pharmaceutical Company
Location: Chandigarh, India

 Pharma Franchise + Third Party Manufacturing

Biophar Lifesciences is one of India’s most trusted pharmaceutical companies for diabetic medicine PCD franchise and third-party manufacturing services. With WHO–GMP certifications, modern infrastructure, and strict quality standards, Biophar provides high-demand anti-diabetic products like Dapagliflozin + Glimepiride + Metformin ER at competitive rates with 100% quality assurance. We offer exclusive monopoly rights, customized product design & packaging, and complete marketing support, helping pharma distributors, wholesalers, and healthcare entrepreneurs establish a profitable diabetes-care business in India. If you are looking for a reliable partner for diabetic medicine franchise or contract manufacturing, Biophar Lifesciences delivers excellence with consistency.

📝 Keywords (SEO)

• Dapagliflozin Glimepiride Metformin tablets manufacturer

• Anti-diabetic PCD pharma franchise India

• Diabetes medicine third-party manufacturing

• Dapagliflozin + Metformin + Glimepiride ER Tablets

• Biophar Lifesciences diabetes product range

• PCD Pharma Franchise for anti-diabetic medicines